SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): February 21, 2014
LIFEPOINT HOSPITALS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware | | 000-51251 | | 20-1538254 |
(State or Other Jurisdiction
of Incorporation) | | (Commission File Number) | | (IRS Employer
Identification No.) |
330 Seven Springs Way
Brentwood, Tennessee | | 37027 |
(Address of Principal Executive Offices) | | (Zip Code) |
(615) 920-7000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On February 21, 2014, LifePoint Hospitals, Inc. (the “Company”) entered into a trading plan (the “Plan”) in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 as amended (the “Act”), under which the Company may continue to repurchase its shares at times when the Company would not ordinarily be in the market due to the Company’s trading policies or possession of material non-public information. This plan has been established pursuant to, and as part of, the Company’s stock repurchase program. As previously announced, the Company has an existing share repurchase authorization, which is effective through August 20, 2014, of which $158.4 million remained available as of February 21, 2014. In addition, on February 12, 2014, the Company’s board of directors authorized an additional stock repurchase program of up to $150 million of the Company’s common stock over an 18 month period beginning on April 1, 2014.
The Plan will expire on March 31, 2014, unless terminated earlier in accordance with its terms. The Company does not retain or exercise any discretion over purchases of common stock under the Plan. The timing and extent of the repurchases under the Plan are subject to SEC regulations as well as certain price, market volume and timing constraints specified in the plan.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | LIFEPOINT HOSPITALS, INC. |
| | |
| | |
| By: | /s/ Paul D. Gilbert | |
| | Name: | Paul D. Gilbert | |
| | Title: | Executive Vice President and Chief Legal Officer | |
| | | | |
Dated: February 21, 2014 | | | | |
| | | | | |
3
